Exiqon, MultiD Analyses partnership leads to advanced GenEx qPCR data analysis program development

NewsGuard 100/100 Score

Exiqon A/S, a leader in microRNA analysis products and services, and MultiD Analyses AB, a leader in comprehensive software solutions for qPCR data analysis, today announced a Development and Distribution Agreement  incorporating a specifically adapted version of the GenEx qPCR analysis software for Exiqon's new microRNA qPCR platform. The agreement allows Exiqon to sell a fully compatible and comprehensive data analysis solution to complete their microRNA qPCR offering. 

"The partnership between MultiD and Exiqon has lead to the development of a customized version of the advanced GenEx data analysis program which has been specifically adapted to allow easy  pre-processing and analysis of data from the Exiqon microRNA PCR panels and assays," said Henrik M. Pfundheller, VP Sales & Marketing of Exiqon. "Exiqon offers the best performing qPCR reagents for microRNA expression profiling on the market. However, we feel it is just as important that our customers process, normalize and analyze their qPCR data properly and with confidence. The addition of the Exiqon GenEx software to our microRNA qPCR portfolio enables customers to get the most out of their microRNA expression profiling experiments in an easy and convenient way."

"We have developed a special Plate Design module which enables Exiqon's customers to design their qPCR experiment in silico and generate templates for import into their real-time PCR instrument," said Mikael Kubista, Chairman of MultiD. "These templates also allow fast and easy import of the results into GenEx for pre-processing and analysis. The Exiqon GenEx software really streamlines the experimental process from planning through generation of results to data analysis." 

MultiD's GenEx software is well established software for processing and analysis of qPCR data. It includes everything from selection and validation of reference genes, data pre-processing and advanced statistical methods to analyze real-time qPCR data with simple clicks of the mouse. Possibly the most important part of qPCR experiments is the pre-processing of raw data for subsequent statistical analysis. Pre-processing steps need to be performed with consistence, in the correct order and with confidence. GenEx has a streamlined and user-friendly interface which aids data handling.  Powerful presentation tools generate professional illustrations of even the most complex experimental designs. 

Exiqon's miRCURY LNA™ Universal RT microRNA PCR system offers the best available combination of performance and ease-of-use on the microRNA real-time PCR market. The use of two LNA™-enhanced PCR primers results in both exceptional sensitivity and specificity, enabling both accurate quantification of very low microRNA levels and discrimination between closely related microRNA sequences. The universal RT step greatly reduces sample input requirements and technical variation, and most importantly saves time in the laboratory. The product line includes microRNA Ready-to-Use PCR panels for exceptionally sensitive expression profiling of 730 human microRNAs, individual microRNA assays, reference gens and reagent kits. 

Source:

Exiqon A/S

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Largest genetic study of gestational diabetes discovers nine novel genetic regions linked to severe and common pregnancy complication